Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTempest Therapeutics board director resigns, waives unpaid fees
Filed May 29, 2026 · Period ending May 23, 2026 · ~1 min read
Key Changes
-
medium
Board member Ms. Simantov resigned effective May 23, 2026, with no stated disagreement on company operations, policies, or practices.
Item 5.02 verify on EDGAR → -
low
Departing director waived all accrued and unpaid retainer fees under the non-employee director compensation program as part of separation agreement.
Item 5.02 verify on EDGAR →
Summary
Tempest Therapeutics disclosed that board director Ms. Simantov resigned effective May 23, 2026. The company explicitly stated her departure was not due to any disagreement with management regarding operations, policies, or practices—standard language meant to signal an amicable exit. As part of her separation agreement, Ms.
Simantov waived unpaid retainer fees owed under the director compensation program, though her existing stock options and share ownership remain intact. For retail investors, board departures warrant attention but this appears routine. The waiver of fees suggests a clean break and may slightly benefit the company's cash position. Watch for any follow-on disclosures about board composition changes or new director appointments in coming weeks, which could signal strategic shifts or governance priorities.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Board director Ms. Simantov resigned effective May 23, 2026, waiving unpaid retainer fees; no disagreement with company cited.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The Separation Agreement provides for the waiver by Ms. Simantov of all accrued and unpaid retainer fees in accordance with the Company’s non-employee director compensation program
As part of her departure, Ms. Simantov waived all unpaid retainer fees owed to her under the director compensation program. Her existing stock options and share ownership remain unaffected, and her indemnification agreement stays in force for six years.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 29, 2026 · How we verify